BioHarvest Sciences to Webcast Live at VirtualInvestorConferences.com October 27th

BioHarvest Sciences Inc (OTCQB:CNVCF) (CSE:BHSC), a global leader in plant cell biology, today announced that CEO Ilan Sobel will be presenting live at VirtualInvestorConferences.com on October 27^th, 2022.

Available for 1×1 meetings: October 28, 31

This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.

It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates.

Learn more about the event at www.virtualinvestorconferences.com.

Recent Company Highlights

• On October 25, BioHarvest released the composition results of its first Cannabis product, which was grown in its bioreactors from source hemp plant cells
  • Demonstrates unprecedented Cannabinoids tuning and elicitation capabilities (12X increase versus original plant) using its proprietary Bio-Plant CELLicitation™ platform technology
  • Contains high amounts of minor Cannabinoids such as THCV (2.5%) and CBDV (4.4%) providing unique medical and commercial benefits
  • The Company plans to reveal additional information related to its high THC Cannabis product line by year end
• Currently in active discussions with US Multi State Operators
• In the regulatory process for Israeli Cannabis production license
• VINIA, the first product produced on BioHarvest’s platform, just announced record Q3 Sales of $1.71 M
• September-Awarded 2022 Sustainability Leadership Award from The Business intelligence Group:
  • Water usage – 54x more cannabis grown per liter of water utilized as compared to indoor cultivation
  • Electricity Productivity – 8x more Cannabis grown per kilowatt hour
  • Land Usage – 19x more Cannabis output per square metre per 12 months

About BioHarvest Sciences Inc.
BioHarvest Sciences Inc. (CSE: BHSC) is a fast-growing Biotech firm listed on the Canadian Securities Exchange. BioHarvest has developed a patented bio-cell growth platform technology capable of growing the active and beneficial ingredients in fruit and plants, at industrial scale, without the need to grow the plant itself. This technology is economical, ensures consistency, and avoids the negative environmental impacts associated with traditional agriculture. BioHarvest is currently focused on nutraceuticals and the medicinal cannabis markets. Visit: www.bioharvest.com.

About Virtual Investor Conferences^®
Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.

Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access.  Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.

CONTACTS:
BioHarvest Sciences Inc
Justin Meiklem
Head of Investor Relations
778.686.3855
[email protected]

Virtual Investor Conferences
John M. Viglotti
SVP Corporate Services, Investor Access
OTC Markets Group
(212) 220-2221
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/f5dd6c7a-e356-42cb-ac00-587a33959cc0

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.